10x Genomics Blog Dec 22, 2025 10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
BioWorld Dec 22, 2025 Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors
FierceBiotech Dec 22, 2025 AstraZeneca flunks phase 3 lung cancer test in further setback to synthetic lethal mechanism
Agilent Dec 22, 2025 Wasatch Biolabs announces co-marketing agreement with Agilent to advance native-read targeted sequencing - News-Medical
Agilent Dec 22, 2025 Agilent Technologies : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com
Agilent Dec 22, 2025 Osaic Holdings Inc. Has $8.02 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Endpoints News Dec 22, 2025 Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline